Indobufen
Vertebral Artery Stenosis
Beijing Tiantan HospitalSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
3 Active assets in the Vertebral Artery Stenosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Acetylsalicylic Acid Beijing Tiantan Hospital | D | |
Plavix Beijing Tiantan Hospital | D | |
Ticagrelor Beijing Tiantan Hospital | D |
Same molecule, other indications
Indobufen is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →